top of page

SAPA-NE 27th Annual Conference

Sat, Jun 14

|

Boston Marriott Cambridge

Accelerating Innovations in Drug Discovery and Development: Pioneering the Path to Breakthrough Therapies

Tickets are not on sale
See other events
SAPA-NE 27th Annual Conference
SAPA-NE 27th Annual Conference

Event Time

Jun 14, 2025, 8:00 AM – 6:00 PM EDT

Boston Marriott Cambridge, 50 Broadway, Cambridge, MA 02142, USA

About the Event

[Brochure]


Parking:

Parking is available at the nearby Kendall Square Green Garage located at 90 Broadway, Cambridge, MA 02142. As a courtesy to SAPA-NE Annual Conference attendees, we are pleased to offer parking vouchers at a discounted rate of $10 for a duration of 10 hours. (Over 10 hours will incur the standard daily fee of $48/day.)


27th SAPA-NE Annual Conference comprises a full-day program focusing on multi-front industry topics including AI/ML application in research and development and other trends in the ever-evolving life science industry in the Boston/Cambridge region.


Note: Please email "bd@sapa-neweb.org" for conference sponsorship opportunity


Member discount code available:

Exclusive coupon codes for members ($45 off for regular members and $25 off for student members) have been sent to registered emails associated with active memberships. If you are a new member or have not received your code, please contact us at info@sapa-neweb.org for further assistance.


Note: All sales are final and NO refund shall be issued. 


Accelerating Innovations in Drug Discovery and Development:

Pioneering the Path to Breakthrough Therapies


Session I

Entrepreneurs and Drug Hunters: Driving Breakthrough to Address Unmet Medical Needs

Greg Verdine, Ph.D. CEO LifeMine, Professor and Entrepreneur

Manny Simons, M.D., Ph.D. Senior VP, Eli Lilly

Yuhong Qiu, Ph.D. Senior VP, Legend Biotech

Jennifer Dovey, Ph.D. CSO, Triveni Bio


Session II

AI/ML and Data Science in Drug Discovery and Development

Jeb Keiper, Former CEO, Nimbus

Maria Wendt, Ph.D. Global Head of DBSI, Sanofi


Session III

Emerging Discovery Platform and Technology to Accelerate Innovation

Yi Zhang, Ph.D. Director, Kymera Therapeutics

Yao Zhang, Ph.D. Executive Director, GSK

Peter Luo, Ph.D. CEO, President of R&D and Chairman, Adagene


If you have any questions, please feel free to contact info@sapa-neweb.org

Share This Event

bottom of page